Survey of Osteoarthritis Real World Therapies (SORT) - SORT

Syreon Corporation0 个研究点目标入组 200 人开始时间: 待定最近更新: 2024年5月6日

适应症

试验速览

暂无简介。

•INCLUSION CRITERIA
•1. Male or female subjects who are at least 50 years of age at the time of enrollment.
•2. Subjects with a clinical diagnosis of primary osteoarthritis of the knee(s) .
•3. Subjects who are presently receiving prescribed oral or topical analgesics for a minimum duration of two weeks prior to enrollment.
•4. Subjects who have provided informed consent and are willing and able to follow the protocol.

•EXCLUSION CRITERIA
•1. Subjects with any arthritis other than primary osteoarthritis.
•2. Subjects who are or have been treated with DMARDS, methotrexate or biologics.
•3. Subjects considered by the investigator to be unwilling or unable to complete the study or unable to comprehend or complete the study questionnaires.
•4. Subjects who are unwilling to comply with the protocol or who are unable to complete the questionnaires.
•5. Subjects with active litigation and compensation issues including disability dispute cases with government.
•6. Subjects with subtotal or total joint replacement in the affected knee.
•7. Subjects with chronic severe pain of other causes that in the opinion of the investigator may require long-term analgesia or confound the present study.
•8. Subjects currently enrolled in a clinical trial or who have participated in a clinical trial within the past 30 days.

发起方

Syreon Corporation